Edition:
United States

Laboratorios Farmaceuticos ROVI SA (ROVI.MC)

ROVI.MC on Madrid SE C.A.T.S.

14.87EUR
23 Mar 2017
Change (% chg)

€0.62 (+4.35%)
Prev Close
€14.25
Open
€14.60
Day's High
€14.87
Day's Low
€14.50
Volume
16,420
Avg. Vol
11,735
52-wk High
€15.39
52-wk Low
€10.80

ROVI.MC

Chart for ROVI.MC

About

Laboratorios Farmaceuticos ROVI SA (ROVI) is a Spain-based company principally engaged in the pharmaceutical industry. The Company’s main activities include the development and commercialization, nationwide and abroad, of medicines and drugs. Its products are structured into three fields: Diagnostic, which offers contrast... (more)

Overall

Beta: 0.44
Market Cap(Mil.): €712.50
Shares Outstanding(Mil.): 50.00
Dividend: 0.18
Yield (%): 0.98

Financials

  ROVI.MC Industry Sector
P/E (TTM): 26.84 28.87 29.63
EPS (TTM): 0.53 -- --
ROI: 12.54 13.48 13.01
ROE: 14.99 14.39 14.16

BRIEF-Rovi to begin registration of its biosimilar enoxaparin in Europe

* Completes marketing authorization request procedure of its biosimilar enoxaparin in 26 European Union (EU) countries

Mar 07 2017

BRIEF-Rovi signs deal to distribute Neparvis in Spain

* Signs deal with Novartis Farmaceutica to distribute Neparvis, a drug for symptomatic chronic heart failure, in Spain

Nov 22 2016

More From Around the Web

Earnings vs. Estimates